The World Orphan Drug Congress Europe heads to Amsterdam for the first time, uniting experts and leaders from rare disease research, patient advocacy, biotech, and pharma to make this the must-attend R&D event in Europe

Sessions will span the full spectrum of orphan drug development, including Regulatory & Policy, Gene and Cell Therapy, Clinical Trial Design, Pricing & Reimbursement, Real World Evidence, Patient Engagement, and more.